drugset / Trial / NCT01243567
Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will evaluate the safety and efficacy of bimatoprost/timolol fixed combination (GANfort®) versus latanoprost (Xalatan®) in patients with open-angle glaucoma who have never been previously treated and are at high risk for progression.
Timeline
- Start
- 2010-06-01
- Primary completion
- 2012-02-14
- Completion
- 2012-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bimatoprost | Other / unclassified | 0.03 % | Other |
| Comparator | Latanoprost | Small molecule | 0.005 % | Other |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |